References
- Naviaux RK, Naviaux JC, Li K, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2016;113(37):1–2.
- Blaser MJ. Missing microbes: how the overuse of antibiotics is fueling our modern plagues. New York (NY): Henry Holt; 2014.
- Sonnenburg ED, Smits SA, Tikhonov M, et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016;529(7585):212–2.
- Berstad A, Undseth R, Lind R, et al. Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? Scand J Gastroenterol. 2012;47:914–919.
- Undseth R, Berstad A, Klow NE, et al. Abnormal accumulation of intestinal fluid following ingestion of an unabsorbable carbohydrate in patients with irritable bowel syndrome: an MRI study. Neurogastroenterol Motil. 2014;26(12):1686–1693.
- Arslan G, Gilja OH, Lind R, et al. Response to intestinal provocation monitored by transabdominal ultrasound in patients with food hypersensitivity. Scand J Gastroenterol. 2005;40(4):386–394.
- Morotomi M, Watanabe T, Suegara N, et al. Distribution of indigenous bacteria in the digestive tract of conventional and gnotobiotic rats. Infect Immun. 1975;11(5):962–968.
- Savage DC. Microbial interference between indigenous yeast and lactobacilli in the rodent stomach. J Bacteriol. 1969;98(3):1278–1283.
- Sjölund M, Wreiber K, Andersson DI, et al. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med. 2003;139(6):483–487.
- Hertzberger R, Arents J, Dekker HL, et al. H2O2 production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase. Appl Environ Microbiol. 2014;80(7):2229–2239.
- Fitzgerald P, Cassidy EM, Clarke G, et al. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil. 2008;20(12):1291–1297.
- Zelante T, Iannitti RG, Cunha C, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372–385.
- Barbaro MR, Di SA, Cremon C, et al. Interferon-gamma is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism. Am J Physiol Gastrointest Liver Physiol. 2016;310:G439–G447. ajpgi.
- Bessede A, Gargaro M, Pallotta MT, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature. 2014;511(7508):184–190.
- Naviaux RK. Oxidative shielding or oxidative stress? J Pharmacol Exp Ther. 2012;342(3):608–618.
- Molavian HR, Kohandel M, Sivaloganathan S. High concentrations of H2O2 make aerobic glycolysis energetically more favorable for cellular respiration. Front Physiol. 2016;7:362.
- Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010;25(2):252–258.
- Berstad A, Raa J, Midtvedt T, et al. Probiotic lactic acid bacteria - the fledgling cuckoos of the gut? Microb Ecol Health Dis. 2016;27:31557.
- Benno P, Befrits R, Norin E, et al. Is irritable bowel syndrome a dysbiotic bowel syndrome? Microb Ecol Health Dis. 2015;26:27637.
- Berstad A, Raa J, Valeur J. Indole - the scent of a healthy ‘inner soil’. Microb Ecol Health Dis. 2015;26:27997.
- Berstad A, Raa J, Valeur J. Tryptophan: ‘essential’ for the pathogenesis of irritable bowel syndrome? Scand J Gastroenterol. 2014;49(12):1493–1498.
- Nongonierma AB, FitzGerald RJ. Milk proteins as a source of tryptophan-containing bioactive peptides. Food Funct. 2015;6(7):2115–2127.
- Shimizu M. Interaction between food substances and the intestinal epithelium. Biosci Biotechnol Biochem. 2010;74(2):232–241.
- Samsel A, Seneff S. Glyphosate, pathways to modern diseases II: celiac sprue and gluten intolerance. Interdiscip Toxicol. 2013;6(4):159–184.